Surgery has been considered the standard treatment of benign prostatic hyperplasia (BPH) in patients with severe obstructive disorders of micturition occurring in the advanced stages of the disease. In early stages, pharmacological therapies (hormonal, non-hormonal, phytoderivatives) capable of improving urological disturbances and of delaying surgery can be of valid help in the management of BPH. Phytoderivatives, containing several active constituents which may exert additive and/or synergistic actions, are reported to be generally well tolerated and to have minimal side effects with a very good risk/benefit ratio.
|Number of pages||10|
|Publication status||Published - 1997|
- Benign prostatic hyperplasia (BPH)
- Medical treatment
ASJC Scopus subject areas